These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34909041)

  • 1. Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents.
    Malekzadeh M; Dadkhah S; Khodarahmi GA; Asadi P; Hassanzadeh F; Rostami M
    Res Pharm Sci; 2022 Feb; 17(1):22-34. PubMed ID: 34909041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation.
    Emami L; Hassani M; Mardaneh P; Zare F; Saeedi M; Emami M; Khabnadideh S; Sadeghian S
    BMC Chem; 2024 Jul; 18(1):125. PubMed ID: 38965630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3.
    Taherian E; Khodarahmi G; Khajouei MR; Hassanzadeh F; Dana N
    Res Pharm Sci; 2019 Jun; 14(3):247-254. PubMed ID: 31160902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave Assisted Synthesis and Molecular Docking Studies of Some 4- (3H)-quinazolinone Derivatives as Inhibitors of Human Gamma- Aminobutyric Acid Receptor, the GABA (A)R-BETA3 Homopentamer.
    Amrutkar RD; Ranawat MS
    Med Chem; 2021; 17(5):453-461. PubMed ID: 31840612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides.
    Pedrood K; Taayoshi F; Moazzam A; Iraji A; Yavari A; Ansari S; Sajjadi-Jazi SM; Mohajeri-Tehrani MR; Garmsiri N; Haghpanah V; Soleymanibadi M; Larijani B; Hamedifar H; Adibpour N; Mahdavi M
    Heliyon; 2023 Feb; 9(2):e13528. PubMed ID: 36873155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular docking, and cytotoxicity of quinazolinone and dihydroquinazolinone derivatives as cytotoxic agents.
    Taayoshi F; Iraji A; Moazzam A; Soleimani M; Asadi M; Pedrood K; Akbari M; Salehabadi H; Larijani B; Adibpour N; Mahdavi M
    BMC Chem; 2022 May; 16(1):35. PubMed ID: 35585608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents.
    Emami L; Khabnadideh S; Faghih Z; Farahvasi F; Zonobi F; Gheshlaghi SZ; Daili S; Ebrahimi A; Faghih Z
    BMC Chem; 2022 Nov; 16(1):100. PubMed ID: 36419100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety.
    Zare S; Emami L; Faghih Z; Zargari F; Faghih Z; Khabnadideh S
    Sci Rep; 2023 Sep; 13(1):14461. PubMed ID: 37660139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic evaluation of some derivatives of triazole-quinazolinone hybrids.
    Hassanzadeh F; Sadeghi-Aliabadi H; Nikooei S; Jafari E; Vaseghi G
    Res Pharm Sci; 2019 Apr; 14(2):130-137. PubMed ID: 31620189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinazoline analogues as cytotoxic agents; QSAR, docking, and
    Emami L; Sabet R; Khabnadideh S; Faghih Z; Thayori P
    Res Pharm Sci; 2021 Oct; 16(5):528-546. PubMed ID: 34522200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Molecular Dynamics Simulation, and
    Nili Ahmadabadi M; Rezaee E; Nematpour M; Karami L; Mokhtari S; Kobarfard F; Tabatabai SA
    Iran J Pharm Res; 2022 Dec; 21(1):e133840. PubMed ID: 36915409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some novel dibromo-2-arylquinazolinone derivatives as cytotoxic agents.
    Faghih Z; Rahmannejadi N; Sabet R; Zomorodian K; Asad M; Khabnadideh S
    Res Pharm Sci; 2019 Apr; 14(2):115-121. PubMed ID: 31620187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, molecular docking studies and biological evaluation of some novel hybrids based on quinazolinone, benzofuran and imidazolium moieties as potential cytotoxic and antimicrobial agents.
    Asadi P; Khodarahmi G; Jahanian-Najafabadi A; Saghaie L; Hassanzadeh F
    Iran J Basic Med Sci; 2017 Sep; 20(9):975-989. PubMed ID: 29085591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study.
    Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al-Mishari AA; Attia SM
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic evaluation of some new 3-(2-(2-phenylthiazol-4-yl) ethyl)-quinazolin-4(3H) one derivatives with potential anticancer effects.
    Hosseinzadeh L; Aliabadi A; Rahnama M; Sadeghi HMM; Khajouei MR
    Res Pharm Sci; 2017 Aug; 12(4):290-298. PubMed ID: 28855940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation.
    Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M
    Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.
    Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA
    Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives.
    Mphahlele MJ; Gildenhuys S; Parbhoo N
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.